Sept 30 (Reuters) - Australian biotech giant CSL CSL.AX on Tuesday said Ken Lim, its chief strategy officer, will assume the role of chief financial officer starting October 7, 2025, as Joy Linton prepares to retire.
(Reporting by Adwitiya Srivastava in Bengaluru; Editing by Sahal Muhammed)
((Adwitiya.Srivastava@thomsonreuters.com;))